Abstract:Down syndrome (DS) is the most example of aneuploidy, resulting from an additional copy of all or part of chromosome 21. Competing endogenous RNAs (ceRNAs) play important roles in neuronal development and neurological defects. This study aimed to identify hub genes and synergistic crosstalk among ceRNAs in the DS fetal hippocampus as potential targets for the treatment of DS-related neurodegenerative diseases. We profiled differentially expressed long non-coding RNAs (DElncRNAs), differentially expressed circular RNAs (DEcircRNAs), differentially expressed microRNAs (DEmiRNAs), and differentially expressed messenger RNAs (DEmRNAs) in hippocampal samples from patients with or without DS. Functional enrichment analysis and gene set enrichment analysis were performed, and chromosome 21-related ceRNA and protein–protein interaction networks were constructed. Additionally, the correlations between lncRNA-mRNA and miRNA-mRNA expression in the samples and HEK293T cells were validated. Our finding of changes in the expression of some key genes and ncRNAs on chromosome 21 in DS might not fully conform to the gene dosage hypothesis. Moreover, we found that four lncRNAs ( MIR99AHG , PLCB4 , SNHG14 , GIGYF2 ) and one circRNA ( hsa_circ_0061697 ) may competitively bind with three miRNAs ( hsa-miR-548b-5p , miR-730-5p , and hsa-miR-548i ) and subsequently regulate five mRNAs ( beta-1,3-galactosyltransferase 5 [ B3GALT5 ], helicase lymphoid-specific [ HELLS ], thrombospondin-2 [ THBS2 ], glycinamide ribonucleotide transformylase [ GART ], clathrin heavy chain like 1 [ CLTCL1 ]). These RNAs, whether located on chromosome 21 or not, interact with each other and might activate the PI3K/Akt/mTOR and Wnt signaling pathways, which are involved in autophagosome formation and tau hyperphosphorylation, possibly leading to adverse consequences of trisomy 21. These findings provide researchers with a better understanding of the fundamental molecular mechanisms underlying DS-related progressive defects in neuronal development.

Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome

Oxidative Stress and Down Syndrome. Do Antioxidants Play a Role in Therapy?

Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics

Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21

Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children

The burden of trisomy 21 disrupts the proteostasis network in Down syndrome

Trisomy 21-driven metabolite alterations are linked to cellular injuries in Down syndrome

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Chromosomal and cellular therapeutic approaches for Down syndrome: A research update

Single‐cell landscape analysis reveals systematic senescence in mammalian Down syndrome

Autophagy and Its Comprehensive Impact on ALS

A Novel Mechanism Underlying Pathogenesis of Down Syndrome

Nrf2 stabilization prevents critical oxidative damage in Down syndrome cells

Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome

Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities

Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine β-synthase, H2S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy

A Common Link Between Alzheimer's Disease and Down Syndrome

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells

Competing Endogenous RNAs Crosstalk in Hippocampus: A Potential Mechanism for Neuronal Developing Defects in Down Syndrome

Down Syndrome and Autoimmune Disease